Ekkehard Mittelstaedt_Web

STADA AG Successfully Moves to Arvato Systems' Private Cloud

Improved performance by switching from On Premise to SaaS

The Move to the Cloud - All Services from a Single Source

For many years now, the trend has been to move applications to the cloud and use them holistically as Software as a Service, or SaaS for short. Companies buy a scalable and highly available service as a web-based solution. The entire management, including updates and security management, can be taken over by their provider. The data and the application itself are made available in a cloud environment.

Logo Stada

Already for the implementation of the EU FMD (Falsified Medicines Directive) requirements in 2016, STADA successfully used the "Arvato CSDB" for the serialization of prescription drugs. In order to be able to work even more efficiently, the application has now moved to the virtual private cloud of Arvato Systems.


Concentration on the core business
Clear responsibilities
Faster problem resolution
Reliable IT security

With NAVOO®, we have achieved our goal of ensuring efficient and secure global collaboration for B. Braun employees with just one innovative solution. The satisfaction of our employees in their daily teamwork speaks for the success of the project.

B. Braun

Project Overview

Background situation

STADA and Arvato Systems have already been working closely together since 2016 to implement the EU FMD requirements successfully. With the Arvato Corporate Serialization Database (CSDB), secure drug identification could be ensured. As a pharmaceutical group, STADA AG must meet the highest IT security requirements, work efficiently and be able to focus on its core business, the production of pharmaceuticals. This is where the migration of a Software as a Service - SaaS for short - comes into play.


"Cloud" is an important, unavoidable topic for all companies worldwide. To remain competitive, independent, and future-oriented, the use of a cloud is indispensable. STADA AG is also following this trend and relies on the experience and promise of the highest IT security from Arvato Systems.


As an experienced operator of our own data centers, we at Arvato Systems can make STADA AG a promise: secure and, at the same time, flexible cooperation. We have been able to prove this over the past six years. Now, thanks to our virtual private cloud, they receive an even more stable application with the same level of performance. In addition, there are fewer support interfaces and, ultimately, a minimized coordination effort.

since 2016
Go Live
February 01, 2022

About STADA Arzneimittel AG

STADA Arzneimittel AG is headquartered in Bad Vilbel, Hesse. The company relies on a three-pillar strategy consisting of generics, specialty pharmaceuticals, and non-prescription consumer healthcare products. STADA Arzneimittel AG sells its products in around 120 countries worldwide. In 2021, STADA achieved Group sales of €3,249.5 million and earnings before interest, taxes, depreciation, and amortization (EBITDA) of €776.5 million. As of December 31, 2021, STADA employed 12,520 people worldwide.

This Might Also Be Interesting

Serialization with Arvato CSDB

Arvato CSDB - Serialization in drug production

National Verification Systems

Arvato Systems provides European countries with a National Blueprint Service to verify medicines.

Counterfeit proof medicines

Implementation of Arvato CSDB - IT solution for successful drug serialization according to the Falsified Medicines Directive.

Your Contact for Questions about Our Solutions

Ekkehard Mittelstaedt_Web
Ekkehard Mittelstaedt
Expert for Digitization in the Healthcare and Pharmaceutical Industry